← Back to The Signal

Technology

A Remote Patient Monitoring Platform Comparison 2026: A Buyer's Guide for Clinics

By Sameer Sontakey

An educational evaluation framework for clinic administrators comparing third-party remote monitoring platforms — covering device evidence, CPT documentation, EHR integration, and vendor accountability.

Choosing a remote patient monitoring platform in 2026 involves evaluating a range of third-party vendors and device types. Clinics need to assess data quality, documentation requirements, and enrollment support against the intended use of their program.

Remote patient monitoring platform selection should start with clinical workflow fit, validated device data, billing documentation, adherence among people enrolled, and EHR integration—not with a feature checklist alone.

remote patient monitoring platform verification checklist

  • Confirm which physiologic data are collected, whether devices are FDA-cleared when required, and how missing data are handled.
  • Map CPT documentation needs, escalation protocols, and staff time before signing a vendor contract.
  • Review security, consent, onboarding for people enrolled, EHR integration, and export access for quality reporting.

Authoritative references include the CMS digital health coverage resources, CMS care management payment resources, and FDA Digital Health Center of Excellence.

Remote patient monitoring platform selection criteria

A remote patient monitoring platform should be evaluated as a clinical operations system, not just a device dashboard. Clinics need to know whether the platform supports qualifying physiologic data, onboarding for people enrolled, alert review, billing documentation, and escalation workflows before signing a vendor contract.

The strongest remote patient monitoring platform choices make data provenance clear: which device generated the measurement, whether the reading passed quality checks, who reviewed it, and how it flowed into the chart. A remote patient monitoring platform comparison should therefore include data access, EHR integration, CPT documentation, and support burden, not only device price.

For multi-condition programs, the remote patient monitoring platform should also separate consumer wellness trends from clinically reviewable signals. That distinction protects billing integrity and helps care teams avoid alert fatigue.

This guide is written for clinic administrators, medical directors, and telehealth directors who need to make a defensible, auditable vendor decision. We cover what to evaluate, how the major platform categories differ, and the specific questions you should put to every vendor before signing a contract.

What to Evaluate Before Choosing an RPM Platform

Before comparing vendors side by side, a clinic needs clarity on its own requirements. The most common mistake in RPM procurement is selecting a platform based on a demo rather than on a structured needs assessment. Six dimensions should anchor that assessment.

Device intended use and evidence. Review each device’s stated intended use, applicable regulatory authorization, validation population, and measurement limitations. Consumer, clinical, and research labels alone do not establish accuracy, regulatory status, or reimbursement eligibility.

Data ownership. Who owns the physiological data generated by the people in your care? Some platforms retain rights to de-identified data for secondary use. For hospital systems and academic medical centers running prospective studies, this is non-negotiable — data must remain within your governance boundary. Review the data processing agreement, not just the BAA.

EHR integration. Bidirectional HL7 FHIR integration with Epic or Cerner is table stakes for high-volume programs. Confirm whether the vendor has a certified SMART on FHIR app, a direct integration, or a manual CSV export workflow. Manual export is workable for pilots; it does not scale.

Billing support. Review current requirements for each setup, supply, and treatment-management code. Ask what documentation the platform generates and what staff must create manually; do not assume a vendor’s billing features establish eligibility.

Onboarding complexity. Ask vendors for documented activation and data-completeness rates, including how those measures are defined and which populations they describe. Evaluate the setup support required for the people in your program.

Condition coverage. A platform designed for diabetes management may have excellent CGM integration but limited support for cardiac or pulmonary monitoring. Confirm that the device portfolio matches the people in your care.

RPM Platform Categories

Platforms differ in clinical scope, device support, and operational functions. Evaluate those differences directly rather than inferring them from a category label.

General remote monitoring platforms may combine device procurement, billing documentation, and care coordination. Verify which functions are included and which remain the clinic’s responsibility.

Condition-specific platforms focus on a particular monitoring need, such as glucose measurements or ECG recordings. Check the intended use and supported measurements of each offering rather than assuming coverage of other biometric streams.

Key Evaluation Criteria

The following seven criteria provide the structured framework for a defensible vendor comparison.

Device Accuracy and Validation

Ask every vendor for device-specific validation study citations and applicable regulatory documentation. Review the authorized intended use, measurement method, study population, and limitations. Do not infer validation for a different population or use from a regulatory label alone.

Data Granularity

Ask whether the platform supplies summary metrics, time-series measurements, or raw waveforms. Request sample exports and verify timestamps, missing-data handling, and any restrictions on access. The data needed should follow from the program’s intended use, not from a platform’s marketing category.

Biometric Signal Coverage

Evaluate sensor coverage against the program’s clinical question and each device’s intended use. Check which measurements are continuous versus spot-check, and whether raw waveform data is accessible or only processed metrics. A longer list of signals does not establish suitability for a particular condition.

EHR Integration

Confirm HL7 FHIR R4 compliance and, specifically, which FHIR resource types are supported (Observation, Patient, Device, CarePlan). Vendor claims of "Epic integration" range from a certified SMART on FHIR app to a manual HL7 v2 file drop. The former is operationally viable; the latter creates FTE burden. Ask for the integration architecture document, not just a feature checklist.

Billing and CPT Documentation

For programs billing CPT 99457 (first 20 minutes monthly) and 99458 (additional 20-minute increments), the platform must generate time-stamped interaction logs and device data transmission records. Ask specifically: does the platform generate a CMS-compliant monthly summary report, or does your team assemble that documentation manually?

Participation Support Tools

Evaluate alert threshold configuration, escalation pathways, and engagement tools such as app notifications and check-in prompts. Ask for evidence before accepting claims that these features improve participation, reimbursement, or clinical outcomes.

Data Ownership and HIPAA Compliance

Confirm the vendor will execute a Business Associate Agreement. Review whether data about people enrolled is used for any secondary purpose, including platform improvement or AI model training. For health systems operating under state privacy laws more stringent than HIPAA (California CMIA, for example), confirm the vendor's compliance posture under applicable state law.

Questions to Ask Every RPM Vendor

Use this list as the foundation for your RFP or vendor discovery calls. Any vendor unable to answer these questions with specificity is not ready for clinical deployment at scale.

  • What device validation studies support your accuracy claims, and in which populations were they conducted?
  • Do you provide access to raw physiological waveform data, or only processed summary metrics?
  • What is your HL7 FHIR version support, and which FHIR resource types are included in your integration?
  • Do you have a certified SMART on FHIR application available in the Epic App Orchard or Cerner App Gallery?
  • What CPT documentation does the platform generate automatically, and what must our staff produce manually?
  • Who owns the data about people enrolled, and is it used for any secondary purpose including platform improvement or AI model training?
  • What is your BAA structure, and have you completed HIPAA compliance assessments under applicable state privacy laws?
  • What is your historical activation rate across client deployments, and how do you define activation?
  • What is your uptime SLA, and what is your incident response process for data transmission failures?
  • Can you provide three client references from organizations with a similar population and program scope to ours?

Billing and Reimbursement Considerations

Remote patient monitoring reimbursement depends on the applicable code, payer, and service requirements. Setup, device supply, and treatment management have distinct documentation rules.

Check the current requirements for CPT 99457 and 99458 separately from device-supply requirements. Document qualifying services, time, and communication according to the relevant payer policy rather than assuming one monitoring-day threshold applies to every code.

For programs incorporating therapeutic rather than purely physiological monitoring, the RTM CPT codes 98975–98981 cover a separate service category. Understanding the boundary between RPM and remote therapeutic monitoring is essential for programs that monitor adherence, musculoskeletal function, or respiratory therapy. The two billing pathways cannot be billed concurrently for the same service period under most payer policies.

Payer coverage beyond Medicare varies significantly. Commercial payer policies for RPM range from full coverage with documentation requirements similar to Medicare to no coverage at all. Medicaid coverage is state-by-state. Before deploying an RPM program, confirm reimbursement coverage for the specific CPT codes with each payer in the people in your care. For a detailed comparison of RTM vs RPM billing structures, see our dedicated guide.

References

  1. Centers for Medicare & Medicaid Services. Telehealth & Remote Monitoring. MLN901705. December 2025.
  1. Centers for Medicare & Medicaid Services. Therapy Code List: 2026 Annual Update. MLN Matters MM14250. November 24, 2025.

FAQ

What is the difference between RPM and RTM?
Remote patient monitoring (RPM) involves the collection of physiological data — blood pressure, heart rate, glucose, SpO2, weight — using medical devices. Remote therapeutic monitoring (RTM) involves the collection of non-physiological data related to therapeutic adherence and response, such as medication adherence, musculoskeletal performance, or respiratory therapy compliance. The two are governed by different CPT code families and have different device and documentation requirements. See our RTM vs RPM comparison for a detailed breakdown.
What should a clinic verify before billing RPM?
Review current code descriptors and payer policies for setup, device supply, and treatment-management services. Confirm device requirements, documentation, monitoring duration, communication, and eligible billing practitioners for each code.
Does a device label establish RPM billing eligibility?
No. Review the applicable CMS and payer requirements alongside the device’s regulatory status and intended use. FDA registration, clearance, and billing eligibility are distinct questions; one does not establish the others.
How should a clinic evaluate a device for its monitoring program?
Start with the intended use, then review device-specific evidence, regulatory status, measurement limits, and the population studied. Labels such as consumer or research do not establish suitability for clinical decisions or reimbursement.
What signals should a monitoring program collect?
Signal selection depends on the clinical question and the intended use of each device. Require evidence for the specific measurement and population rather than treating a larger sensor list as proof of clinical utility.